← FDA DRUG APPROVALS
FDA ANDA · ANDA217343
TIMOLOL MALEATE
timolol maleate ophthalmic
Sponsor: MICRO LABS
APPLICATION
ANDA217343
TYPE
ANDA
ORIGINAL APPROVAL
2023-05-26
LATEST ACTION
2023-05-26
ROUTE
OPHTHALMIC
DOSAGE FORM
SOLUTION/DROPS
MARKETING STATUS
Prescription
Products
TIMOLOL MALEATEPrescription
TIMOLOL MALEATE EQ 0.25% BASE · SOLUTION/DROPS · OPHTHALMIC
TIMOLOL MALEATEPrescription
TIMOLOL MALEATE EQ 0.5% BASE · SOLUTION/DROPS · OPHTHALMIC
Approval history
2023-05-26UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.